Adamas Pharmaceuticals reported 129.04M in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 175.38M 3.05M
Adamas Pharmaceuticals ADMS:US 129.04M 671K
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Aptinyx Inc APTX:US $ 14.04M 14.04M
Biocryst Pharmaceuticals BCRX:US $ 304.16M 10.51M
Flexion Therapeutics FLXN:US $ 250.5M 28.96M
GlaxoSmithKline GSK:LN 25605M 122M
Glaxosmithkline GSK:US $ 25605M 122M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Heron Therapeutics HRTX:US $ 149.03M 0.05M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 40.58M 29.61M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Novartis NOVN:VX SF 34243M 1526M
Omeros OMER:US $ 313.02M 433K
Prothena PRTA:US $ 0M 0M
Revance Therapeutics RVNC:US $ 280.32M 0.32M
Teva Pharmaceutical TEVA:IT 23.75B 1.39B
Zogenix ZGNX:US $ 155.87M 2.24M